Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

CTI Life Sciences Fund

CTI Life Sciences Fund?uq=kzBhZRuG
VC INVESTOR TYPE
Active STATUS
4 PROFESSIONALS
31 INVESTMENTS
11 PORTFOLIO
10 EXITS
Description

CTI Life Sciences Fund is a venture capital investment firm based in Montreal, Canada. The firm was established in 2006 and prefers to invest in the life sciences and healthcare companies at the pre-clinical and clinical development stages located in the United States and Canada.

Investor Status
Actively Seeking New Investments
Year Founded
2006
Primary Investor Type
Venture Capital
Primary Office
  • 1 Place Ville-Marie
  • Bureau 1050
  • Montreal, Quebec H3B 4S6
  • Canada

+1 (514) 000-0000

CTI Life Sciences Fund Investments (31)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
SutroVax 19-May-2018 Later Stage VC 0000 Drug Discovery
00000000 05-Oct-2017 00000 00000 000.00 Biotechnology Generating Revenue
0000000000 27-Jul-2017 00000 00000 0000 Medical Supplies Startup
00000 0000000 27-Jun-2017 00000 00000 0000 Database Software Generating Revenue 000000000 000000 00.0
00000000 21-Mar-2017 00000 00000 0000 Drug Discovery Pre-Clinical Trials
000000000 0000000 10-Mar-2017 00000 00000 00.00 Therapeutic Devices Generating Revenue 000000000 000000 00.0
00000 000000000000 26-Sep-2016 0000 00000 0000 Biotechnology Clinical Trials - Phase 1 0000-00000000 00000000
000000 00000000000 13-May-2016 00000 00000 0000 Biotechnology Clinical Trials - Phase 3
Zymeworks 08-Jan-2016 Mezzanine 000.00 Biotechnology Clinical Trials - General 000000000 000000 00.0
PHEMI Systems 28-Jul-2015 Early Stage VC 000.00 Database Software Startup 000000000 000000 00.0
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore CTI Life Sciences Fund’s full profile, request a free trial.

CTI Life Sciences Fund Exits (9)

Company Name Exit Date Exit Type Exit Size Status Buyers
Xagenic 25-Jan-2018 Merger/Acquisition Completed
  • General Atomics
0000000 28-Sep-2017 0000000000: 000000 Completed
000000000 28-Apr-2017 000 0000 Completed
000000 00000000000 01-Jan-2016 000 00 00000000 Completed
00000000 000000 01-Jan-2015 000000000000000000 00.000 Completed
  • 000000 00000000000
00000000 20-Sep-2013 000000000000000000 00000 Completed
  • 0000000000 000000
000000 000000 07-Feb-2012 000000000000000000 00.00 Completed
  • 0000000
Chlorion Pharma 01-Jan-2011 Out of Business Completed
TargeGen 21-Jul-2010 Merger/Acquisition 00000 Completed
To view this investor’s complete exits history, request access »

CTI Life Sciences Fund Team (6)

Name Title Deals Funds Boards Office Contact
Info
Jean-Francois Leprince Managing Partner 0 0 0 Montreal, Canada
Shermaine Tilley Ph.D Managing Partner 00 0 0 Montreal, Canada
Ken Pastor General Partner 0 0 0 Montreal, Canada
Laurence Rulleau Ph.D Partner & Principal 0 Montreal, Canada

2 Former Team Members

You’re viewing 4 of 6 team members. Get the full list »